{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T07:26:57Z","timestamp":1789370817228,"version":"build-2803163510"},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.psychres.2011.01.011","type":"journal-article","created":{"date-parts":[[2011,2,15]],"date-time":"2011-02-15T10:21:02Z","timestamp":1297765262000},"page":"327-330","source":"Crossref","is-referenced-by-count":40,"title":["Effects of antipsychotics on the serum BDNF levels in schizophrenia"],"prefix":"10.1016","volume":"189","author":[{"given":"Chien-Chih","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiao-Lai","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2011.01.011_bb0005","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/39885","article-title":"Anterograde transport of brain-derived neurotrophic factor and its role in the brain","volume":"389","author":"Altar","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.psychres.2011.01.011_bb0010","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/1097-4547(20000615)60:6<783::AID-JNR11>3.0.CO;2-M","article-title":"Brain-derived neurotrophic factor and tyrosine kinase receptor TrkB in rat brain are significantly altered after haloperidol and risperidone administration","volume":"60","author":"Angelucci","year":"2000","journal-title":"Journal of Neuroscience Research"},{"key":"10.1016\/j.psychres.2011.01.011_bb0015","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/sj.mp.4002009","article-title":"Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research","volume":"12","author":"Arranz","year":"2007","journal-title":"Molecular Psychiatry"},{"key":"10.1016\/j.psychres.2011.01.011_bb0020","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0278-5846(01)00159-2","article-title":"Schizophrenia, a neurodegenerative disorder with neurodevelopmental antecedents","volume":"25","author":"Ashe","year":"2001","journal-title":"Progress in Neuropsychopharmacology & Biological Psychiatry"},{"key":"10.1016\/j.psychres.2011.01.011_bb0025","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/jnr.10440","article-title":"Expression of brain-derived neurotrophic factor mRNA in rat hippocampus after treatment with antipsychotic drugs","volume":"71","author":"Bai","year":"2003","journal-title":"Journal of Neuroscience Research"},{"key":"10.1016\/j.psychres.2011.01.011_bb0030","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0006-8993(02)03215-8","article-title":"Differential regulation of hippocampal BDNF mRNA by typical and atypical antipsychotic administration","volume":"954","author":"Chlan-Fourney","year":"2002","journal-title":"Brain Research"},{"key":"10.1016\/j.psychres.2011.01.011_bb0035","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.biopsych.2004.01.020","article-title":"Neuroplasticity and schizophrenia","volume":"56","author":"Frost","year":"2004","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.psychres.2011.01.011_bb0040","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jpsychires.2006.01.005","article-title":"Reduced serum BDNF levels in schizophrenic patients on clozapine or typical antipsychotics","volume":"41","author":"Grillo","year":"2007","journal-title":"Journal of Psychiatric Research"},{"key":"10.1016\/j.psychres.2011.01.011_bb0045","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.psychres.2008.06.030","article-title":"The acute response of plasma brain-derived neurotrophic factor as a result of exercise in major depressive disorder","volume":"169","author":"Gustafsson","year":"2009","journal-title":"Psychiatry Research"},{"key":"10.1016\/j.psychres.2011.01.011_bb0050","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.jpsychires.2005.11.004","article-title":"Associations between serum brain-derived neurotrophic factor levels and clinical phenotypes in schizophrenia patients","volume":"40","author":"Huang","year":"2006","journal-title":"Journal of Psychiatric Research"},{"key":"10.1016\/j.psychres.2011.01.011_bb0055","first-page":"408","article-title":"Associations between brain-derived neurotrophic factor G196A gene polymorphism and clinical phenotypes in schizophrenia patients","volume":"30","author":"Huang","year":"2007","journal-title":"Chang Gung Medical Journal"},{"key":"10.1016\/j.psychres.2011.01.011_bb0060","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.schres.2008.01.017","article-title":"Low serum levels of brain-derived neurotrophic factor and epidermal growth factor in patients with chronic schizophrenia","volume":"101","author":"Ikeda","year":"2008","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.psychres.2011.01.011_bb0065","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0304-3940(02)00529-3","article-title":"Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets","volume":"328","author":"Karege","year":"2002","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.psychres.2011.01.011_bb0070","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1192\/S0007125000291514","article-title":"The Positive and Negative Syndrome Scale (PANSS): rationale and standardisation","author":"Kay","year":"1989","journal-title":"The British Journal of Psychiatry. Supplement"},{"key":"10.1016\/j.psychres.2011.01.011_bb0075","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.neulet.2007.05.064","article-title":"Increased plasma brain-derived neurotrophic factor levels in chronic smokers following unaided smoking cessation","volume":"423","author":"Kim","year":"2007","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.psychres.2011.01.011_bb0080","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1385\/JMN:14:1-2:027","article-title":"Expression of neurotrophins BDNF and NT-3, and their receptors in rat brain after administration of antipsychotic and psychotrophic agents","volume":"14","author":"Linden","year":"2000","journal-title":"Journal of Molecular Neuroscience"},{"key":"10.1016\/j.psychres.2011.01.011_bb0085","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1046\/j.1460-9568.2001.01633.x","article-title":"BDNF mRNA expression in rat hippocampus and prefrontal cortex: effects of neonatal ventral hippocampal damage and antipsychotic drugs","volume":"14","author":"Lipska","year":"2001","journal-title":"The European Journal of Neuroscience"},{"key":"10.1016\/j.psychres.2011.01.011_bb0090","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.neurobiolaging.2004.03.002","article-title":"The impact of age, weight and gender on BDNF levels in human platelets and plasma","volume":"26","author":"Lommatzsch","year":"2005","journal-title":"Neurobiology of Aging"},{"key":"10.1016\/j.psychres.2011.01.011_bb0095","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/sj.mp.4000730","article-title":"Cytokine and growth factor involvement in schizophrenia\u2013support for the developmental model","volume":"5","author":"Nawa","year":"2000","journal-title":"Molecular Psychiatry"},{"key":"10.1016\/j.psychres.2011.01.011_bb0100","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.pnpbp.2004.05.008","article-title":"Low serum levels of brain-derived neurotrophic factor in patients with schizophrenia do not elevate after antipsychotic treatment","volume":"28","author":"Pirildar","year":"2004","journal-title":"Progress in Neuropsychopharmacology & Biological Psychiatry"},{"key":"10.1016\/j.psychres.2011.01.011_bb0105","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.pnpbp.2008.04.007","article-title":"Investigation of serum BDNF levels in drug-naive patients with schizophrenia","volume":"32","author":"Rizos","year":"2008","journal-title":"Progress in Neuropsychopharmacology & Biological Psychiatry"},{"key":"10.1016\/j.psychres.2011.01.011_bb0110","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3109\/15622970802182733","article-title":"Reduced serum BDNF levels in patients with chronic schizophrenic disorder in relapse, who were treated with typical or atypical antipsychotics","volume":"11","author":"Rizos","year":"2010","journal-title":"The World Journal of Biological Psychiatry"},{"key":"10.1016\/j.psychres.2011.01.011_bb0115","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.neulet.2003.08.004","article-title":"Serum brain-derived neurotrophic factor (BDNF) levels in schizophrenia are indistinguishable from controls","volume":"351","author":"Shimizu","year":"2003","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.psychres.2011.01.011_bb0120","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.euroneuro.2004.12.005","article-title":"The possible role of neurotrophins in the pathogenesis and therapy of schizophrenia","volume":"15","author":"Shoval","year":"2005","journal-title":"European Neuropsychopharmacology"},{"key":"10.1016\/j.psychres.2011.01.011_bb0125","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.neulet.2005.02.054","article-title":"Decreased BDNF in serum of patients with chronic schizophrenia on long-term treatment with antipsychotics","volume":"382","author":"Tan","year":"2005","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.psychres.2011.01.011_bb0130","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0165-1781(02)00127-0","article-title":"Decreased levels of brain-derived neurotrophic factor in serum of chronic schizophrenic patients","volume":"110","author":"Toyooka","year":"2002","journal-title":"Psychiatry Research"},{"key":"10.1016\/j.psychres.2011.01.011_bb0135","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/mp.2008.109","article-title":"Meta-analysis of the BDNF Val66Met polymorphism in major depressive disorder: effects of gender and ethnicity","volume":"15","author":"Verhagen","year":"2010","journal-title":"Molecular Psychiatry"},{"key":"10.1016\/j.psychres.2011.01.011_bb0140","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.modgep.2006.03.009","article-title":"BDNF and trkB mRNA expression in the hippocampus and temporal cortex during the human lifespan","volume":"6","author":"Webster","year":"2006","journal-title":"Gene Expression Patterns"},{"key":"10.1016\/j.psychres.2011.01.011_bb0145","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S0140-6736(95)91386-6","article-title":"From neuropathology to neurodevelopment","volume":"346","author":"Weinberger","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.psychres.2011.01.011_bb0150","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/j.pnpbp.2009.08.011","article-title":"Decreased serum BDNF levels in chronic institutionalized schizophrenia on long-term treatment with typical and atypical antipsychotics","volume":"33","author":"Xiu","year":"2009","journal-title":"Progress in Neuropsychopharmacology & Biological Psychiatry"},{"key":"10.1016\/j.psychres.2011.01.011_bb0155","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.pnpbp.2007.03.010","article-title":"Treatment with risperidone for 4weeks increased plasma 3-methoxy-4-hydroxypnenylglycol (MHPG) levels, but did not alter plasma brain-derived neurotrophic factor (BDNF) levels in schizophrenic patients","volume":"31","author":"Yoshimura","year":"2007","journal-title":"Progress in Neuropsychopharmacology & Biological Psychiatry"},{"key":"10.1016\/j.psychres.2011.01.011_bb0160","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3109\/15622970802309617","article-title":"Different patterns of longitudinal changes in plasma levels of catecholamine metabolites and brain-derived neurotrophic factor after administration of atypical antipsychotics in first episode untreated schizophrenic patients","volume":"11","author":"Yoshimura","year":"2010","journal-title":"The World Journal of Biological Psychiatry"},{"key":"10.1016\/j.psychres.2011.01.011_bb0165","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.jpsychires.2006.08.007","article-title":"Serum BDNF levels and weight gain in schizophrenic patients on long-term treatment with antipsychotics","volume":"41","author":"Zhang","year":"2007","journal-title":"Journal of Psychiatric Research"}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016517811100045X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016517811100045X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T11:06:12Z","timestamp":1559991972000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016517811100045X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S016517811100045X"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2011.01.011","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}